Use the search to find what you are looking for

CANCER OF UNKNOWN PRIMARY FOUNDATION

OnHealthy

Australian SUPER-NEXT study to measure the clinical value of the ‘whole genome’ approach to CUP receives $5M funding

June 3, 2020

SUPER is an Australian  CUP trial that has been running for some time and as part of it  SUPER-NEXT, led by Richard Tothill, will evaluate WGS when used to help resolve a tumour type diagnosis and improve therapeutic decision making in CUP. 



← Back to blog